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should be more amenable to crys-
tallization. How does PI3K activation 
assist in the pheromone response? 
Slessareva et al. (2006) show that it 
may help Gβγ to activate MAP kinase, 
but possible mechanisms for this 
are hard to fathom given our current 
knowledge. Finally, the authors pro-
pose that Gα might cycle between 
GDP and GTP bound forms at the 
endosome, and this would require 
a nucleotide exchange factor at the 
endosome to catalyze the cycle. 
Could this exchange factor sim-
ply be an endocytosed pheromone 
receptor acting in the same manner 
as it does at the plasma membrane, 
or is some new exchange factor 
required? Despite these unresolved 
issues, Slessareva et al. (2006) 
make a major contribution to our 
understanding of heterotrimeric G 
protein signaling by identifying an 
intracellular G protein effector and 
establishing its physiological signifi-
cance in signaling through rigorous 
genetic tests.
Is yeast pheromone signaling rel-
evant to signaling in humans? Any-
one who doubts this should look to 
history. Studies of yeast pheromone 
signaling first established that Gβγ 
could activate downstream signal-
ing events. The first member of the 
RGS class of Gα GTPase activators 
was also identified through stud-
ies of pheromone signaling. In both 
cases, it was years before it was 
appreciated that signaling in ver-
tebrates works the same way. The 
identification of PI3K as an intrac-
ellular G protein effector is the first 
major addition to the yeast pherom-
one signaling pathway in over 10 
years. There is already a hint that 
heterotrimeric G proteins regulate 
lipid kinases at intracellular mem-
branes in mammalian cells (Jamora 
et al., 1999), and we look forward to 
follow-up studies.
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A change in the shape of mitochondrial cristae must take place to attain rapid and complete 
release of cytochrome c during apoptosis. In this issue of Cell, Cipolat et al. (2006) and 
Frezza et al. (2006) show that a rhomboid intramembrane protease PARL and a dynamin-
related protein OPA1 are critical regulators of cristae remodeling.Structurally speaking, the convo-
luted folds (cristae) of the mito-
chondrial inner membrane were 
once viewed simply as a barrier that 
separated the mitochondria into the 
inner matrix and the intermembrane 
space (IMS). The pioneering studies 
of mitochondrial structure by Man-
nella, Frey, and coworkers using 
electron tomography changed this 
view. They showed that the lamellar and tubular structure of the mito-
chondrial inner membrane gener-
ates a third type of compartment, 
created by juxtaposition of inner-
membrane folds. These intra-cris-
tae regions form a barrier to diffu-
sion of proteins (Frey and Mannella, 
2000). This shifting view of mito-
chondrial structure has important 
implications for our understanding 
of apoptosis.Cell 12Several apoptogenic proteins, 
in particular cytochrome c, reside 
in the mitochondrial IMS. Predic-
tions based on studies using elec-
tron tomography suggest that most 
cytochrome c is “trapped” in the 
intra-cristae regions, with limited 
access to the IMS (Figure 1). Two 
steps are required for the release 
of cytochrome c from mitochon-
dria. The first involves remodeling of 6, July 14, 2006 ©2006 Elsevier Inc. 27
figure 1. OPA1 slows down cytochrome 
c Release by Maintaining Tight cristae
Prior to the permeabilization of the mito-
chondrial outer membrane, matrix remod-
eling is required for a swift and complete re-
lease of cytochrome c. OPA1 comes in two 
sizes: the larger form is embedded in the 
mitochondrial inner membrane (IM) and the 
smaller soluble form is found in the inter-
membrane space (IMS) and plays a critical 
role in maintaining the bottleneck structure 
of the cristae. PARL, an intramembrane pro-
tease, regulates OPA1 processing. During 
apoptosis, the OPA1 hetero-oligomer is dis-
rupted, leading to unraveling of the cristae 
and cytochrome c diffusion to the IMS. Fol-
lowing perforation of the mitochondrial out-
er membrane (usually due to Bak/Bax activ-
ity), cytochrome c is released to the cytosol 
where it forms the apoptosome (oligomers 
of Apaf-1, cytochrome c, and pro-caspase-
9) and leads to further downstream events 
that trigger full-blown apoptosis.28 Cell 126, July 14, 2006 ©2006 Elseviethe cristae configuration, eliminat-
ing the diffusion barrier and freeing 
cytochrome c from the cristae to the 
IMS. The second step is the release 
of cytochrome c into the cytosol 
via pores in the mitochondrial outer 
membrane (Figure 1) (Scorrano et al., 
2002). Although the final release of 
cytochrome c through the mitochon-
drial outer membrane requires the 
proapoptotic Bcl-2 family proteins 
Bak and Bax, cristae remodeling 
does not. Two reports in this issue 
of Cell show that cristae remodeling 
during apoptosis, which leads to the 
release of cytochrome c, is regulated 
by a rhomboid protease PARL and a 
dynamin-related protein OPA1 (Cipo-
lat et al., 2006; Frezza et al., 2006).
Cristae remodeling was not the 
first link established between mito-
chondrial structure and apoptosis. 
As their Greek name implies, mito- 
(thread) chondria (grains) are pleio-
morphic organelles. They form either 
short rod-like structures or continu-
ous filamentous structures (or “spa-
ghetti and meatballs” as coined by 
Paolo Bernardi and John Lemas-
ters). These structures are shaped 
by opposing mechanisms: mitochon-
drial fusion and mitochondrial fission 
(Youle and Karbowski, 2005). Mito-
chondrial fusion and fission in yeast 
and mammals are very similar and 
the players known thus far are con-
served between the species. These 
include the extended dynamin fam-
ily of proteins (Danino and Hinshaw, 
2001): mitofusin (MFN) 1 and 2 (Fzo1 
in yeast) and OPA1 (Mgm1) required 
for mitochondrial fusion and DRP1 
(Dnm1) required for mitochondrial 
fission (for a detailed list see Youle 
and Karbowski, 2005).
Youle and coworkers characterized 
the first link between mitochondrial 
fission and apoptosis, showing that 
DRP1 is essential for cytochrome c 
release (Frank et al., 2001). Subse-
quent studies described the pro- 
and antiapoptotic roles of proteins 
involved in mitochondrial fission or 
fusion, respectively (Youle and Kar-
bowski, 2005). However, the mecha-
nism by which mitochondrial fission 
may contribute to cytochrome c 
release has remained elusive. It was r Inc.then shown that DRP1 induces cris-
tae remodeling in addition to its role 
in mitochondrial fission (Germain et 
al., 2005), but whether this second 
function of DRP1 requires mitochon-
drial fission is unclear.
The two new reports in this issue 
provide insights into the mechanism 
of cristae remodeling during apop-
tosis (Cipolat et al., 2006; Frezza et 
al., 2006). Surprisingly, the stars of 
this performance are PARL (Rbd1 
in yeast) and OPA1 (Mgm1), which 
are known to regulate mitochon-
drial fusion in yeast (McQuibban 
et al., 2003). Both reports indicate 
that the antiapoptotic effects of 
these proteins are independent of 
mitochondrial fusion, yet there are 
functional similarities between the 
mammalian and the corresponding 
yeast proteins. Both PARL and Rbd1 
are rhomboid proteases, which are 
intramembrane serine proteases, 
and both are localized to the mito-
chondrial inner membrane. The new 
reports suggest (though they do 
not directly show) that as in yeast, 
where Mgm1 is a substrate of Rbd1 
(McQuibban et al., 2003), mitochon-
drial PARL cleaves the OPA1 protein. 
The cleavage of OPA1 generates a 
pool of truncated OPA1 that is solu-
ble in the IMS. This soluble OPA1 is 
crucial for the antiapoptotic effects 
of PARL because it maintains the 
bottleneck configuration of cristae 
and the compartmentalization of 
cytochrome c (Figure 1).
The study by Cipolat et al. (2006) 
reveals that mice lacking PARL die 
shortly after 8 weeks of age with 
progressive cachexia manifested 
mostly by muscle loss. The spleen 
and thymus of PARL-deficient mice 
were also severely atrophic. Consid-
ering that Rbd1-deficient yeast can-
not grow on nonfermentable medium 
(McQuibban et al., 2003) and that 
myopathy is a common feature of 
mitochondrial disorders, it was rea-
sonable to assume that PARL-defi-
cient mice have a severe defect in 
oxidative phosphorylation. However, 
studies of mitochondria isolated 
from tissues of PARL-deficient mice 
could not reveal such a defect. On 
the other hand, extensive apopto-
sis was detected in lymphocytes, 
explaining the loss of mass in the 
spleen and thymus. Cipolat et al. 
therefore suggested that apoptosis 
may explain muscle fiber loss and 
went on to characterize the role of 
PARL in apoptosis. Using mouse 
embryonic fibroblasts (MEFs), they 
confirmed that PARL protects cells 
from the intrinsic, mitochondria-
dependent, apoptotic pathway but 
not from extrinsic stimuli, such as 
treatment with TNFα. Because Rbd1 
cleaves Mgm1 in yeast, and because 
OPA1, its mammalian homolog, is 
known to have antiapoptotic activity, 
the authors investigated the role of 
OPA1 in PARL’s antiapoptotic activ-
ity. Interestingly, overexpression of 
OPA1 had antiapoptotic effects in 
wild-type MEFs but not those lacking 
PARL. In contrast, reducing expres-
sion of OPA1 in PARL-deficient cells 
using short hairpin RNAs (shRNAs) 
circumvented the antiapoptotic 
effect of PARL added exogenously. 
This indicated that neither of these 
proteins has antiapoptotic activity 
independent of the other. Borrowing 
from the yeast system, Cipolat et al. 
investigated whether PARL cleaves 
OPA1, generating a short form that is 
antiapoptotic. Indeed, they observed 
that these proteins interact on the 
mitochondrial inner membrane. They 
also found a short form of OPA1 in 
the IMS region of mitochondria from 
wild-type cells. This short form of 
OPA1 was less abundant in the IMS 
of PARL-deficient cells. Importantly, 
the overexpression of an IMS-tar-
geted short OPA1 had antiapoptotic 
activity in both wild-type cells and in 
cells lacking PARL. These results are 
consistent with the claim that OPA1 
cleavage is PARL dependent and 
that a shorter form of OPA1, which is 
found in the IMS, mediates the antia-
poptotic activity of PARL.
The work by Frezza et al. (2006) 
provides additional information on 
OPA1 and cristae remodeling. This 
study investigated the mechanisms 
of availability of cytochrome c to 
the IMS. Frezza et al. treated iso-
lated mitochondria with the cleaved 
active form of the proapoptotic Bcl-2 family member Bid (cBid), showing 
that cytochrome c release from the 
mitochondria of cells overexpress-
ing OPA1 was markedly slower than 
for wild-type cells. This finding was 
independent of mitochondrial fusion 
because OPA1 had the same effect 
in cells deficient in MFN1 and MFN2, 
which are required for mitochondrial 
fusion. Furthermore, in mitochondria 
isolated from cells in which OPA1 
expression was reduced by shRNAs 
or inhibited by a dominant-negative 
mutant, cytochrome c release was 
much faster. To show that OPA1 con-
trols cytochrome c release by regu-
lating its accessibility to the IMS, the 
mitochondria were briefly incubated 
with cBid, and cytochrome c mobi-
lization was examined using either 
outer membrane permeabilization 
with a mild detergent or respiratory 
assays. In respiratory assays, ascor-
bate or NADH were used as electron 
donors capable of reducing cyto-
chrome c (directly or indirectly) only 
when it is free in the IMS. Extensive 
studies using electron microscopy 
and electron tomography confirmed 
that OPA1 maintained the bottleneck 
structure of the cristae-IMS junction 
in mitochondria treated with cBid.
These investigators propose a 
mechanism for how the IMS-soluble 
OPA1 that is induced by PARL main-
tains cristae structure. They showed 
that the short and long forms of 
OPA1 form hetero-oligomers that are 
disrupted soon after cBid treatment, 
when cristae remodeling is observed 
and cytochrome c is still retained in 
the IMS. They propose a provoca-
tive model in which OPA1 clamps the 
mitochondrial inner membrane by 
linking the long, membrane bound 
forms with the shorter IMS ones (Fig-
ure 1). Indeed, under hypotonic con-
ditions, when the inner membrane 
swells, OPA1 did not form oligom-
ers, indicating that the disruption of 
cristae structure dissociates OPA1 
heteromers.
The two new studies suggest that 
the PARL-OPA1 duo is required for 
maintaining the tightly folded struc-
ture of the mitochondrial inner mem-
brane. Given that both full-length and Cell 12truncated OPA1 are needed, OPA1 
must first be truncated by PARL to 
achieve a fully functional cristae-
tightening complex. Whether OPA1 
is the only component in this com-
plex has yet to be determined. Unlike 
the case in yeast, OPA1 truncation 
by PARL may not be required for 
mitochondrial fusion because loss of 
PARL does not affect the fusion proc-
ess. This may be explained by the 
fact that small amounts of truncated 
OPA1 are observed in PARL-defi-
cient cells or that truncated OPA1 is 
not required for mitochondrial fusion. 
The fact that the antiapoptotic activ-
ity of OPA1 is independent of its pro-
fusion activity does not rule out the 
need for mitochondrial fission during 
apoptosis. The connection between 
mitochondrial fission and cristae 
remodeling needs further investiga-
tion. In particular, the role of DRP1 in 
regulating cristae structure needs to 
be clarified. Moreover, what leads to 
the dissociation of the OPA1 oligomer 
early after cBid treatment (and other 
apoptogenic signals) is still an open 
question.
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